Clinical Trial Update: Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia [Phase 4]

View source ↗

Summary

Phase 4 trial update on Atmeg (atorvastatin and omega-3) for carotid atherosclerosis in adults with type 2 diabetes mellitus and dyslipidemia; recruitment is on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Dyslipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Atmeg (atorvastatin and omega-3 fatty acids)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Dyslipidemias, Atherosclerosis | Phase 4 | Status: RECRUITING